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Abstract
A simple method is reported to fabricate gold arrays featuring microwells surrounding 8-
electrodes from gold compact discs (CDs) for less than $0.2 per chip. Integration of these
disposable gold CD array chips with microfluidics provided inexpensive immunoarrays that were
used to measure a cancer biomarker protein quickly at high sensitivity. The gold CD sensor arrays
were fabricated using thermal transfer of laserjet toner from a computer-printed pattern followed
by selective chemical etching. Sensor elements had an electrochemically addressable surface area
of 0.42 mm2 with RSD <2%. For a proof-of-concept application, the arrays were integrated into a
simple microfluidic device for electrochemical detection of cancer biomarker interleukin-6 (IL-6)
in diluted serum. Capture antibodies of IL-6 were chemically linked onto the electrode arrays and
a sandwich immunoassay protocol was developed. A biotinylated detection antibody with
polymerized horseradish peroxidase labels was used for signal amplification. The detection limit
of IL-6 in diluted serum was remarkably low at 10 fg mL −1 (385 aM) with a linear response with
log of IL-6 concentration from 10 to 1300 fg mL −1. These easily fabricated, ultrasensitive,
microfluidic immunosensors should be readily adapted for sensitive detection of multiple
biomarkers for cancer diagnostics.
Introduction
Microchip-based electrochemical arrays are gaining importance in bioanalysis due to their
high throughput capability for multiplexed detection and lower cost per analysis.1-10
Numerous methods have been used to fabricate planar electrode arrays. One often-used
approach is to deposit thin layers of metal onto silicon or glass substrates and pattern the
electrodes using standard lithography.11-14 This method offers excellent precision and high
resolution for nano-scale features, but the overall cost and number of steps required limit its
widespread use and applications for disposable devices unless economies of scale can be
achieved. Screen-printing is an alternative to lithography that offers low cost, mass
production and disposability.15-18 Inkjet-printed electronics is being explored due to
versatility, ease of design and ability to manufacture three-dimensional structures. For
example, gold nanoparticle inks have been used to fabricate gold electrode arrays at low
cost19-21 and we adapted one such array for immunosensing.19 While screen and inkjet
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printing significantly decrease fabrication costs, they still require specialized equipment and
technical expertise.
The present paper describes an inexpensive alternative to fabricate high quality, individually
addressable gold electrode arrays with microwells starting from commercial gold compact
discs-recordable (CD-R). These gold CD-R microarrays were integrated into a simple
microfluidic device and used to detect a cancer biomarker protein. Microfluidics minimized
sample volume, gave good control of mass transport, improved throughput and facilitated
partial automation of the assay.22,23
Levels of specific proteins are elevated in blood at the onset of cancer and can be used as
biomarkers for early detection, which promises to greatly improve prognosis for
patients.1,24-28 However, clinical detection of biomarker panels has yet to be broadly
realized due to limitations in existing protein assay methods, sample size, difficulty in
multiplexing, complexity and cost.1 Thus, we have chosen this application for our arrays to
illustrate utility in bioanalysis.
Electrochemical immunoarrays have been developed by Wilson and Nie for measuring up to
seven cancer biomarker proteins in serum at ng mL −1 levels using arrays of iridium oxide
electrodes.4,5 Wei et al. reported microfluidic sensor arrays utilizing a DNA dendrimer/
conducting polymer film to detect oral cancer biomarkers in saliva with a detection limit
(DL) of ~4 fM for interleukin 8 (IL-8) mRNA and 7 pg mL −1 for interleukin-8 (IL-8)
protein.6,7 Screen printed electrode arrays integrated with micro-fluidic platforms have been
used to detect panels of biomarker proteins as possible disposable diagnostic tools.8-10 We
previously developed nanostructured stand-alone immunosensors combined with multilabel
enzyme-antibody detection particles to achieve sub-pg mL −1 DLs for prostate specific
antigen (PSA)29,30 and interleukin-6 (IL-6) in serum.31,32 We also employed a non-micro-
fluidic 4-electrode nanostructured array to simultaneously measure prostate cancer
biomarkers such as PSA, prostate specific membrane antigen (PSMA), platelet factor-4
(PF-4) and IL-6 in cancer patient serum.33 Most recently, we developed a multiplexed
amperometric microfluidic system using off-line protein capture on enzyme-labeled
magnetic beads to achieve DLs ~0.20 pg mL −1 for PSA and IL-6 in serum.8 We interfaced
the microfluidic device from the latter reported with the gold CD microarrays in the present
work.
Gold electrodes were previously fabricated from compact recordable discs (CD-R) by
Angnes et al. and used in conventional cells to detect copper and mercury by potentiometric
stripping.34 Using an office inkjet printer, Yu et al. fabricated microsensors on a gold CD-R
by printing self-assembled monolayers and subsequently wet etching to detect DNA.35,36
Daniel and Gutz and Ferreira et al.37,38 used thermal transference of laserjet toner masks to
produce gold electrode sets and a microfluidic cell. To our knowledge, none of these
approaches have been used to develop individually addressable electrode arrays for
immunoassays.
In this paper, we describe the fabrication and characterization of 8-sensor gold CD-R
derived immunoarrays featuring 1 μL microwells surrounding each sensor element. The cost
of materials is less than $0.2 per array. We demonstrate the integration of these arrays into a
simple microfluidic device for the detection of very low levels of cancer biomarker protein
IL-6 in diluted serum.
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Archival gold compact recordable discs (CD-R) 650 MB were from MAM-A Inc.
(Colorado, USA). Monoclonal anti-human interleukin-6 (IL-6) antibody (clone no. 6708),
biotinylated anti-human IL-6 antibody, recombinant human IL-6 (carrier-free) in calf serum
and streptavidin-horseradish peroxidase (HRP) were from R&D systems. Streptavidin poly-
HRP was from Thermo Scientific (product # N200). Bovine serum albumin (BSA) and
Tween-20 were from Sigma Aldrich. 1-(3-(Dimethylamino) propyl)-3-ethylcarbodiimide
hydrochloride (EDC) and N-hydroxysulfosuccinimide (Sulfo-NHS) from Sigma Aldrich
were dissolved in pH 7.4 phosphate buffered saline (PBS) immediately before use.
Hydrogen peroxide (H2O2, 30%) was from Fisher. The poly(dimethyl)siloxane (PDMS) kit
was from Dow Corning. Immunoreagents were dissolved in pH 7.4 PBS buffer (0.01 M in
phosphate, 0.14 M NaCl, 2.7 mM KCl) unless otherwise noted. Protein standards were
prepared in diluted bovine calf serum (Sigma Aldrich) which has similar properties to
human serum but lacks human proteins.29
Instrumentation
A Hewlett Packet Laserjet Printer 1022n was used to print patterns onto wax paper. A
thermal press (Stahls USA, Maxx Press) was used to transfer printed patterns onto the gold
CD-R. An eight-electrode CHI 1030 electrochemical workstation was used for amperometry
at ambient temperature (22 2 C). Amperometry was done at −0.3 V vs. Ag/AgCl with a flow
rate of 100 μL min −1.
The microfluidic system featured a molded, flexible PDMS channel8 positioned directly
above the 8-sensor (dia. 850 μm ea.) gold array. This assembly was sandwiched between
two flat poly (methylmethacrylate) (PMMA) plates bolted together to provide the
microfluidic channel (Fig. 1). The microfluidic channel is 1.5 mm wide, 2.8 cm long, with
63 μL volume as described previously.8 The top PMMA plate features connections to 0.2
mm i.d. polyether ether ketone (PEEK) tubing for inlet and outlet and Ag/AgCl reference
and Pt counter electrode wires that run along the channel above all eight electrodes. A
syringe pump (New Era Pumping System NE-1000) was used to move fluid within the
microfluidic device. The pump was connected to the inlet of the device via an injector valve
(Rheodyne, 9725i) using 0.2 mm i.d. PEEK tubing (Fig. S3, ESI†).
Atomic force microscopy (AFM) was done using a Digital Instruments Nanoscope IV
scanning probe microscope, in tapping mode with symmetric tip high resolution Tapping
Mode AFM probes (Veeco Metrology Inc., Model MPP-11100).
Preparation of gold CD-R
A gold CD-R consists of four layers: a rigid polycarbonate, an organic dye, a gold metallic
layer and an outer protective layer. The CD-R was immersed in concentrated nitric acid for
1 min to remove the protective layer, and then cut using scissors into desired shapes and
sizes. Cutting the CD-R before removing the protective layer damaged the underlying gold
layers.37 The nitric acid treated CD-R was then washed with water, dried under nitrogen,
and used immediately for array fabrication.
Fabrication of electrode arrays
A mask was designed using the graphic design software package Canvas 11 on a 1: 1 scale
(Fig. S1, ESI†). It was then printed onto waxed paper (obtained from the backing of Avery
labels) using the HP laserjet at 1200 dots per inch (dpi). The mask was then cut and placed
onto a cut piece of gold CD-R processed as above. The CD-R piece and toner mask were
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then sandwiched within the thermal press at 120 −C for 110 s (Scheme 1). The contact area
and working electrode were manually covered by inking with a Sharpie ® permanent marker
before etching.38,39 The ink containing N-butanol, N-propanol, and 4-hydroxy-4-methyl-2-
pentanone in the Sharpie ® provides an excellent etch resist to the gold etchant to protect the
gold film.39 A gold etchant solution containing 0.1 M potassium thiosulfate, 1 M potassium
hydroxide, 0.01 M potassium ferricyanide, and 0.001 M potassium ferrocyanide was used to
remove the unprotected gold.40 The gold on the surface is first oxidized by ferricyanide.
Thio-sulfate then binds to the gold ions and solubilizes them. The solution is basic to
prevent degradation of thiosulfate. Finally, the arrays were washed with ethanol, then water.
This exposes the contact pads and sensor electrodes as shown in Scheme 1(e). After
washing, the arrays were dried under nitrogen. Then, a second layer of laserjet toner was
heat transferred from wax paper onto the arrays to define the surface area of the electrodes
and create hydrophobic microwells around each electrode (Fig. 2b and S2, ESI†).
Preparation of immunosensors for Interleukin-6
The array was cleaned in 0.18 M sulfuric acid while applying 10 cycles of potential sweeps
between 1.5 V and 0.1 V, then rinsed with ethanol and water before immersing into 4 mM
mercapto-propionic acid (MPA) in 20% ethanol for 46 h under N2 to form a self-assembled
monolayer (SAM). The outward facing surface carboxylic groups of MPA were activated
using freshly prepared 400 mM EDC and 100 mM NHSS. The array was rinsed with water
after 10 min and anti-human IL-6 capture antibody (Ab1) was attached by amidization
between the activated carboxylic groups of SAM and the Ab1 using optimized conditions of
1.0 μL of 100 μg mL −1 Ab1 per sensor electrode (8 μL per array) for 3 h. The array was
washed by gently dipping into 0.05% Tween-20 in PBS and then PBS for 3 times each. Each
electrode on the arrays was then incubated with 1.0 μL of 2% BSA for 10 min, followed by
the same washing steps. For standardization, 1.0 μL of the respective concentration of
human IL-6 antigen (Ag) in 5000-fold serially diluted calf serum in pH 7.4 PBS was
dropped onto each electrode and incubated for 1 h. This dilution was used because it
corresponds to that required for bringing clinical samples into the linear range of the
immunoassay. After washing again in 0.05% Tween-20 in PBS, then PBS, each electrode
was incubated with 1.0 μL of 9 μg mL −1 biotinylated anti-human IL-6 secondary antibody
(Ab2) for 1 h. Again, arrays were washed and incubated with 1.0 μL of 1: 500 diluted
streptavidin poly-HRP in PBS for 1 h. The dilution of streptavidin poly-HRP was optimized
to achieve the best signal to noise ratio. All incubations were done at room temperature in
high humidity chambers unless otherwise noted.
After a final wash in 0.05% Tween-20 in PBS, then PBS, the immunoarray was placed in the
microfluidic device for electro-chemical analysis. A mixture of pH 7.4 PBS purged with
nitrogen for 30 min and 1 mM hydroquinone (HQ) was pumped through the channel using
the syringe pump at 100 μL min −1. Detection was done using amperometry at −0.3 V vs.
Ag/AgCl by injecting a deoxygenated mixture of 100 μM H2O2 and 1 mM HQ mediator in
PBS using the sample loop.
Results
Characterization of electrode arrays
Tapping-mode atomic force microscopy (AFM) images (Fig. 3a) revealed grooves in the
gold CD surface41 that were found on the sensor electrodes. After the IL-6 capture
antibodies were covalently linked onto the SAM layer on the gold, AFM images showed a
distribution of globular shaped hills which were more apparent at higher resolution (Fig. 3b
and c). These globular shapes are generally characteristic of high antibody surface
coverage.42
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Cyclic voltammetry (CV) of the bare array in 0.18 M sulfuric acid vs. Ag/AgCl reference
electrode in the microfluidic device between −0.1 V and +1.5 V at 100 mV s −1 (Fig. S5,
ESI†) showed similar peaks to those from bulk gold. Peaks were found for formation of gold
oxide at +1.2 V and reduction of the oxide to bulk gold at −0.9 V.43
The design pattern was set up to print eight disk electrodes with a diameter of 850 μm.
During thermal transfer onto the gold CDs, the toner spreads as expected and reduced the
effective geometric area of the electrodes. After thermal transfer, the diameter of each
electrode was 800 ± 25 μm estimated using fiducial camera images, and the surface area was
0.50 0.03 mm2. The dry resistance of gold arrays from contract pads to working electrodes
was 17.6 0.2 ohms.
To assess reproducibility of the electrochemically addressable area in the absence of
immunosensing, cyclic voltammetry was done on all electrodes on the array simultaneously
in an unstirred solution of 5 mM ruthenium hexamine chloride [Ru (NH3)6]–Cl3 and 0.1 M
sodium trifluoroacetate (NaTFA) after cleaning the gold surface by potential sweeping in
sulfuric acid. Using the Randles–Sevcik equation and the known diffusion coefficient of
ruthenium hexamine chloride,44 the surface area was estimated to be 0.42 ± 0.07 mm2,
which is ~85% of the estimated geometric area with a relative standard deviation of <2%
between electrodes. Amperometric signals were also measured on all electrodes in the
microfluidic device after injection of 100 μM [Ru(NH3)6]-Cl3 solution. All 8 electrodes of
the array gave similar peak currents (Fig. 4b), with an average of 12.2 ± 0.5 nA (RSD <
5%), demonstrating the absence of cross-talk between neighboring electrodes during
microfluidic flow conditions.
Immunoassay development
All sensor arrays were first cleaned by cycling in sulfuric acid to remove gold oxide from
the surface. Then a SAM coating was made by immersing the sensor arrays into MPA
solution. Immunoarrays for interleukin-6 (IL-6) were developed by covalently binding anti-
human IL-6 capture antibody onto the SAM layers on each of the gold sensor surfaces. A
single concentration of IL-6 in diluted serum was used per array and the amount used per
electrode was 1.0 μL (8 μL per array). After full development of the assay, the gold sensor
array was placed into the microfluidic device (Fig. 1). A mixture of 1 mM hydroquinone
mediator and 100 μM hydrogen peroxide was then injected into the microfluidic device via
the 100 μL sample loop to develop the amperometric response. Flow rates were optimized in
the microfluidic device by varying flow rates of the injections between 50 and 250 μL
min −1 to obtain the highest signal to noise ratio as previously described.8 Fresh chips were
used for measuring each standard concentration.
Injections of the peroxide/mediator mixture produced low noise current peaks due to the
conversion of HRP by peroxide to ferryloxy HRP, whose reduction is mediated by
hydroquinone.33 Control experiments included the full immunoassay procedure without
IL-6. The control response reflects the sum of residual non-specific binding and direct
reduction of hydrogen peroxide. Representative amperometric responses are shown in Fig.
5a for a series of concentrations of IL-6 in 5000-fold diluted calf serum in PBS varying from
10 to 1280 fg mL −1. The high dilution factor was chosen to bring clinically relevant IL-6
concentrations into the linear range of the sensor. The DL for IL-6 as 3 times the average SD
above the control was 10 fg mL −1.
Discussion
The above results show that non-lithographic fabrication from gold compact discs offers a
simple and inexpensive route to reproducible and ultrasensitive amperometric arrays for the
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detection of protein biomarkers. A single array as described herein costs less than US $0.20
in materials to produce, and requires no specialized equipment. One of the major advantages
of this technique is the ease of modification of the printed pattern, which is customizable for
virtually any application. This allows rapid development of prototypes using common
graphical software such as PowerPoint ®.
The spreading of reagents and sample solution is a major concern during sandwich
immunoassays on electrochemical arrays. It can cause cross-contamination, decrease
precision, and increase amounts of reagents needed. Solution spreading was eliminated in
the present arrays by creating hydrophobic microwells around the sensor electrodes by
placing a second layer of toner around them. The hydrophobic toner creates a barrier around
individual sensors allowing the confinement of ~ 1 μL of aqueous solution above each
sensor element (Fig. 2b and S2, ESI†). The transference of a second layer of toner onto the
arrays also eliminated human error from manually inking with Sharpie pens and improved
the reproducibility of sensor area to <2% from sensor to sensor. The well-defined and nearly
reversible peaks of the ruthenium redox couple in the cyclic voltammogram (Fig. 4a) with a
peak separation of ~80 mV further indicate that the arrays are suitable for a range of
electrochemical measurement applications. The similarities in amperometric peaks on these
arrays under flowing conditions demonstrated that the electrodes on the array (Fig. 4b)
produced equivalent electrochemical response with minimal cross-talk.
Immunosensing application
IL-6 is an over-expressed protein found in the blood of patients with oral, lung, colorectal
and prostate cancers as well as inflammation.45-48 Serum IL-6 levels of cancer patients can
elevate to thousands of pg mL −1 compared to normal levels of <6 pg mL −1. The low
concentrations of IL-6 in normal serum make it especially challenging for immunoassays.
Thus, amplification techniques must be used to improve the DL for IL-6 protein. In previous
work, we developed single electrode immunosensors utilizing carbon nanotube forests or 5
nm gold nanoparticles to increase surface area allowing more capture antibodies to be
attached.8,19,30-32 Combined with particles labeled with 200 000 HRPs and antibodies
attached, these systems enhanced the detection limit of IL-6 in serum into the sub-pg mL −1
range.8
In this work, we chose an alternative, rapid amplification strategy that substitutes
streptavidin poly-HRP for the more commonly used streptavidin HRP to improve sensitivity
and limit of detection. This streptavidin poly-HRP featured polymers of multiple HRP
molecules conjugated to streptavidin, which bind to the biotinylated secondary antibody.
This supramolecular enzyme complex contains increased molar ratio of HRP enzyme labels
per biotin-streptavidin binding event49,50 while retaining the functionality of the strong
binding couple as shown in Scheme 2. This amplification strategy is implemented simply by
replacing the streptavidin-HRP with streptavidin poly-HRP during the last step of incubation
for attachment to the detection antibody, which is attached to the previously captured
analyte protein. Using the procedures for amperometric detection in the microfluidic device
described above, peak currents increased from 10 fg mL −1 to 1300 fg mL −1 for IL-6
concentration in diluted serum with DL 10 fg mL −1 (Fig. 5b). This ultra-low DL is ~200
times lower than our previously reported immunosensors for IL-6 with 14-16 HRP labels on
single-electrode immunosensors in conventional three electrodes cells and ~30-fold lower
than the DL in our alternative microfluidic immunoassay system employing more expensive
screen printed arrays and magnetic particles with 200 000 HRPs, while offering similar
sensitivity. Similar to this alternative device, good selectivity for IL-6 is indicated by its
successful detection in the presence of the thousands of other proteins present in serum. The
use of microfluidics decreases the amount of reagents and the time required for detection by
roughly 20-fold compared to our previous systems.31,32 Lastly, microfluidics provided
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excellent control of mass transport that improved the signal/noise ratio while making the
detection system more portable.
Conclusions
The above results demonstrate that integration of immunoarrays easily fabricated from gold
CD-Rs into a microfluidic device has excellent potential as a cheap, disposable chip-based
diagnostic tool for early cancer detection and monitoring. The 8-electrode arrays should be
readily adaptable to multiple protein detection and further automation, goals that we are
presently pursuing.
The use of a simple amplification strategy with the gold arrays in a microfluidic system
enabled the immunosensing of IL-6 in diluted serum with DL 10 fg mL −1, well below the
normal patient level. This very low detection limit allows extensive dilution of samples to
help minimize non-specific binding of potentially interfering biomolecules in serum, and
may also be useful in tests for cancer recurrence.
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Fitting the 8-electrode immunoarray into the microfluidic device. The array is sandwiched
between two layers of PMMA and one layer of PDMS acting as microfluidic channel above
the sensor electrodes. The red arrows indicate the flow of buffer.
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(a) Computer generated design of the gold CD-R array showing microwells around
electrodes. (b) Completed array of 8 electrodes with individual microwells containing 1 μL
aqueous droplets.
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Tapping mode AFM images of (a) exposed bare gold CD-R surface, (b) anti-IL-6 capture
antibody attached to the gold CD-R surface. (c) Same as (b) at 10-fold higher resolution
showing globular structures characteristic of attached antibodies.
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Array reproducibility: (a) CVs at 50 mV s −1 on 8-electrodes of a gold CD-R array in 5 mM
([Ru(NH3)6]-Cl3) in aqueous 0.1 M sodium trifluoroacetate (NaTFA). (b) Amperometric
response of the 8-electrode array in the microfluidic device to injection of 100 μL of 100 μM
([Ru (NH3)6]-Cl3) at 100 μL min −1.
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Amperometric data for immunoarray chips after exposure to diluted serum containing IL-6
and HRP-labeled secondary antibody: (a) responses for IL-6 in the microfluidic device at 0.3
V developed by injecting 100 μL 1 mM hydroquinone +100 μM H2O2. (b) Calibration plot
for IL-6 standards in diluted serum after the subtraction of control (n = 6).
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Steps in the fabrication of gold arrays from commercial gold CD-Rs. (a) Remove the
protective layer of the CD-R to expose the gold film; (b) print the array pattern on wax paper
using a laserjet printer and transfer onto the gold surface by applying heat and pressure,
contacts are the squares at the bottom of each chip, electrodes are the circles in the middle of
chip; (c) use a Sharpie ® pen to cover contact pads and electrodes; (d) remove unprotected
gold in etchant solution; (e) wash with ethanol/water to expose contact pads and electrodes;
(f) transfer second layer of toner by heat to form wells.
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Schematic of an amplification strategy using streptavidin poly-HRP. The streptavidin poly-
HRP is attached to the biotinylated anti-human IL-6 detection antibody.
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